Cyclofa-lune (2002) lupus nephritis-randomized controlled multicentric therapeutic comparative study with cyclosporin a versus cyclophosphamide:: Running evaluation

被引：0
|
作者：
Dostál, C
Tesar, V
Rysava, R
Rovensky, J
Rychlik, I
Hrnèíl, Z
Horak, P
Vlasakova, V
Tesar, V
机构：
[1] Charles Univ, Inst Rheumatol, Prague, Czech Republic
[2] Charles Univ, Nefrol Clin, Fac Med 1, Prague, Czech Republic
[3] Inst Rheumatol, Piestany, Slovakia
[4] Charles Univ, Fac Med 3, Nefrol Clin, CR-11636 Prague 1, Czech Republic
[5] Fac Med, Hradec Kralove, Czech Republic
[6] Fac Med, Olomouc, Czech Republic
[7] Dist Hosp, Ceske Budejovice, Czech Republic
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：223 / 224
页数：2
相关论文
共 3 条
  • [1] Cyclosporin A Versus Intravenous Cyclophosphamide in the Treatment of Lupus nephritis: The Cyclofa-Lune Study
    Pesickova, P.
    Zavada, Z.
    Rysava, R.
    Horak, H.
    Hrncir, C. .
    Rychlik, R.
    Vitova, V.
    Lukac, L.
    Dostal, D.
    Tesar, T.
    KIDNEY & BLOOD PRESSURE RESEARCH, 2010, 33 (04): : 316 - 316
  • [2] Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study
    Zavada, J.
    Pesickova, S. S.
    Rysava, R.
    Olejarova, M.
    Horak, P.
    Hrncir, Z.
    Rychlik, I.
    Havrda, M.
    Vitova, J.
    Lukac, J.
    Rovensky, J.
    Tegzova, D.
    Boehmova, J.
    Zadrazil, J.
    Hana, J.
    Dostal, C.
    Tesar, V.
    LUPUS, 2010, 19 (11) : 1281 - 1289
  • [3] VCAM-1, thrombomodulin, anti C1Q antibodies and antinucleosome antibodies serum levels in lupus nephritis treated with Cyclosporine A or cyclophosphamide - Results from cyclofa-lune (2002) study
    Horak, P
    Hermanova, Z
    Budikova, M
    Dostal, C
    Tesar, V
    Zadrazil, J
    Rychlik, I
    Hrncir, Z
    Vlasakova, V
    Rovensky, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 241 - +
1